Skip to main content
Marcin Imielinski, MD, Pathology, Boston, MA

MarcinBImielinskiMDPhD

Pathology Boston, MA

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Clinical Fellow in Pathology, Massachusetts General Hospital

Are you Dr. Imielinski?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 19 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    101 Nicolls Rd
    Boston, MA 11794
    Phone+1 617-726-2967

Summary

  • Dr. Marcin Imielinski, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and New York. He is affiliated with New York-Presbyterian Hospital and is a Clinical Fellow in Pathology at Massachusetts General Hospital.

Education & Training

  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2011 - 2012
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2011
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2008

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2015 - 2025
  • MA State Medical License
    MA State Medical License 2014 - 2015
  • American Board of Pathology Pathology - Clinical
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Press Mentions

  • Molecular Pathology Selected Abstracts
    Molecular Pathology Selected AbstractsOctober 22nd, 2022
  • Whole Exome Sequencing Predicts Whether Patients Respond to Cancer Immunotherapy
    Whole Exome Sequencing Predicts Whether Patients Respond to Cancer ImmunotherapyJuly 12th, 2022
  • Two Investigators Win Pershing Square Sohn Prize for Cancer Research
    Two Investigators Win Pershing Square Sohn Prize for Cancer ResearchMay 28th, 2021
  • Join now to see all